An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients

Condition:   Hepatitis CInterventions:   Drug: Telaprevir;   Drug: ribavirin;   Drug: peginterferon alfa-2aSponsor:   Vertex Pharmaceuticals IncorporatedActive, not recruiting - verified February 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials